Fracture risk in metastatic breast cancer patients treated with CDK 4/6 inhibitors and endocrine therapy. Pedersini R, Moretti L, Lagana M, Schivardi G, et al. Breast Cancer Res Treat 2026;215:58.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Pedersini R, Moretti L, Lagana M, Schivardi G, et al. Fracture risk in metastatic breast cancer patients treated with CDK 4/6 inhibitors and endocrine therapy. Breast Cancer Res Treat 2026;215:58.
PMID: 41557073